Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Dilatrend 25mg°


Contraindicated
Reproductive toxicity in animals

Contraindicated
Dilatrend 25mg° :
Type Medicine Withdrawn
Originator B
Agent Omnipharma
Distributor Omnipharma
Laboratory Cheplapharm
Manufacturer Roche SPA
Origin Italy
ATC C07AG02
Revision Date 01/02/2011

Your comment will appear shortly after approval

Dilatrend 25mg° :

Revision Date : 01/02/2011


Effect Frequency
Abdominal pain Common
Accidental injury Common
Accommodation disorder Common
Allergic exanthema Uncommon
Alopecia Not known
Anaemia Common
Angina pectoris Common
Angina pectoris aggravated Common
Angina unstable Common
Arthralgia (Pain joint) (Joint ache) Common
Asthenia Very Common
Atrial fibrillation Common
Atrioventricular block (AVB) Common
Back pain Common
Blood triglycerides increased Common
Blood urea nitrogen (BUN) increased Common
Bradycardia Very Common
Bronchitis Common
Cardiac failure Common
Cardiac failure aggravated Very rare
Cephalea Common
Chest pain Very Common
Cold extremities Uncommon
Constipation Uncommon
Cough increased Common
Creatine increased Common
Dehydration Common
Depressed mood Uncommon
Diabetes mellitus Common
Diarrhoea (Diarrhea) Very Common
Dizziness Very Common
Drug level increased Common
Dry mouth (Xerostomia) Uncommon
Dyspnoea (dyspnea) Very Common
Eye irritation Uncommon
Fatigue Very Common
First degree atrioventricular block Common
Flu-like syndrome Common
Generalized oedema Common
Gout Common
Haematuria (Hematuria) Common
Hypercholesterolaemia Common
Hyperglycaemia Very Common
Hyperkalaemia Common
Hypertension Common
Hypervolaemia (Hypervolemia) Common
Hypoglycaemia Uncommon
Hypokalaemia Common
Hypotension Very Common
Impotence Uncommon
Infection Common
Infections various Common
Injury Common
Lacrimation decreased Uncommon
Leg oedema Common
Leucopenia (Leukopenia) Very rare
Lichen planus-like reactions Very rare
Lung disease Common
Micturition disorder Uncommon
Muscle cramps Common
Myalgia Common
Myocardial infarction Common
Nasal congestion Uncommon
Nausea Common
Non-protein nitrogen increased (NPN increased) Non-protein nitrogen increased Common
Oedema of extremities Common
Oedema peripheral Common
Orthostatic hypotension Common
Orthostatic symptoms Common
Pain Common
Pain in extremity (Pain in limb) Common
Paraesthesia (paresthesia) Common
Pharyngitis Common
Platelet count decreased (Thrombocyte count decreased) Common
Pneumonia Common
Pruritus Uncommon
Psoriasis Very rare
Pulmonary oedema Common
Pyrexia Common
Renal insufficiency Common
Rhinitis Common
Shortness of breath Common
Sinusitis Common
Sleep disorder (Sleep disturbance) Common
Somnolence Common
Stevens-Johnson syndrome Very rare
Sudden death Common
Sweating increased (Excessive sweating) (Hyperhydrosis) Common
Syncope Common
Transaminases increased Very rare
Upper respiratory tract infection Very Common
Urinary incontinence Very rare
Urinary tract infection Common
Urticaria Uncommon
Ventricular fibrillation Common
Ventricular tachycardia Common
Viral infection Common
Visual disturbance Common
Vomiting Common
Weight increased (weight gain) Very Common

Different Units By MoH Code

Revision Date : 01/02/2011

Dilatrend 25mg° Dilatrend 25mg° Dilatrend 25mg° Dilatrend 25mg° Dilatrend 25mg° Dilatrend 25mg° Dilatrend 25mg° Dilatrend 25mg°

Dilatrend 25mg°  MoH 2769 :
Form Tablet, Scored
Package Size Box of 30
Strength 25mg
Storage Condition <30°C protect from light
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 236654
Submission date 01/01/1999
Registration Year 1999
Withdrawn Date 2019
Barcode 7640128011620


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info